China Securities Network News (reporter Hu Yu) On January 28, Jiangsu Deyuan Pharmaceutical Co., Ltd. (hereinafter referred to as Deyuan Pharmaceutical) was held in Shanghai. Zhang Shu, executive director and sponsor representative of the investment bank headquarters of Kaiyuan Securities Co., Ltd., said that Deyuan Pharmaceutical will still focus on chemical generic drugs in the future and participate in Nanjing Sainuo Biotechnology Co., Ltd., and the two sides will form certain business cooperation in biopharmaceuticals in the future.